Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank67
3Y CAGR-47.2%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-47.2%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$118000.00-
2023$0.00-
2022$0.00-100.0%
2020$800000.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-
2015$0.00-
2014$0.00-